chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SORE THROAT; DRY COUGH; DIARRHEA; TIREDNESS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: Unknown) dose was not reported, 1 in total, administered on 04-MAY-2021 for prophylactic vaccination on his right arm. (dose number in series 1). No adverse events were reported following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855835 expiry: Unknown) dose was not reported, 1 in total, administered on 20-DEC-2021 for prophylactic vaccination on his right arm as booster dose (dose number in series 2). No concomitant medications were reported.  On 30-DEC-2021, the patient experienced sore throat, dry cough, diarrhea, and tiredness. The patient was currently having cough and sore throat, and other symptoms went away on 04-JAN-2022 (dose number in series 2). On 05-JAN-2022, Laboratory data included: COVID-19 (coronavirus disease) antigen test (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, and tiredness on 04-JAN-2022, and had not recovered from sore throat, and dry cough. This report was non-serious.
Child vaccinated at Dr. office on 7/19/2010 and again at Health Department on 7/20/2010.  Child received two MMRs, two Varicella, and 2 Kinrix within 24 hours; Child had low grade fever on 7/20/10 p.m. Central Office called mom 8/18/2010 for followup.  Mother not at home; Unsucessful attempt to reach mom on cell phone; left message; Central Office will continue to call for follow up.
patient came in for the second dose of the primary series pfizer covid vaccine on 01-30-23.  it was noted after administration that the vaccine had the 10 week expiration date of 01-26-23.  patient did not experience any side effects at the time of the event or on 01-31-23 when the patient was contacted regarding the situation.
shaky, itching, hives lt arm same day as shot;DPH given;orange peel appearance to skin 6cm x 10cm (getting larger) possible cellulitis
Can't walk or move too much without my heart rate accelerating making faint or passing out; Can't walk or move too much without my heart rate accelerating making faint or passing out; Heart was constantly at 120 to 130 /can't walk or move too much without her heart rate accelerating; Low blood pressure; Shortness of breath; Tired all the time; This is a spontaneous report from a contactable consumer (patient).   A 32-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: Ew0167), via an unspecified route of administration in Arm Right on 29Apr2021 at 15:00 (at 32 years) as single dose for covid-19 immunisation. Prior to vaccination patient was diagnosed with COVID-19 (positive) and had allergy to sulfa. Concomitant medications were not reported.  On 03May2021 at 04:00 patient experienced heart was constantly at 120 to 130, low blood pressure, shortness of breath, tired all the time, can't walk or move too much without her heart rate accelerating making faint or passing out.  No treatment given. Events resulted in Doctor or other healthcare professional office/clinic visit. Outcome of the events was not recovered. Patient took second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW0178), on 20May2021 at 15:00 (at 32 years) for covid-19 immunisation.
Initial misuse report received on 09-Oct-2013 from a health care professional. An 82-year-old patient (whose gender unknown), medical history and concomitant medications were not reported, received a dose of FLUZONE ID (lot number, route and site of vaccination was not reported) on an unspecified date. It was reported that an 82-year-old patient have received the FLUZONE ID. As of 09-Oct-2013, patient did not have any adverse events. List of documents held by sender: none.
Pt had vaccination in right arm at 1:30 pm on 04/07/2021, started having pain in arm immediately but otherwise felt fine. At 8-9PM pt started feeling short of breath and having chest pain/ palpitations that would not relieve with rest or medications. Pt also stating she had a fever and chills
After giving the vaccination, pt was bleeding more than normal and there was immediate swelling slightly smaller than the size of a quarter in diameter and round  in shape. The pt said she had taken ibuprofen about 1.5 hours before coming to get the vaccination so that could have contributed to the bleeding and swelling, but I think I could have also hit a blood vessel.  I made sure to have the pt stick around for the full 15 min to monitor how she was doing. I provided the pt with an ice pack, asked how she was feeling (she said that it burned slightly when the shot was going in  and it wasn't any more painful than any other shot she's received). After several minutes with the icepack the swelling went down in size. I had her stand up to make sure she wasn't having feeling dizzy or having any trouble breathing.  She said she was feeling ok when she did this.  I told her that if it gets any worse she should call her doctor's exchange.
pt recv vax 16APR99 & has chickenpox;the varivax inj was given 19SEP95;
This spontaneous report as received from a physician via field employee refers to a 17 year old male patient. On an unknown date the patient was vaccinated with (oka/merck) VARIVAX (dose, frequency, route of administration unknown). Pertinent medical history and concomitant medications were unspecified by the reporter. The reporter stated that on an unknown date the patient was diagnosed with his second case of shingles after receiving (oka/merck) VARIVAX. The patient visited office on an unspecified date. The outcome of shingles was unknown. The causality was unknown. No further adverse event information was provided. Additional information has been requested.
S/sx if anaphylaxis within 15-30 min after injection. Pt states throat closing off on drive home. Took BENADRYL and iced arm. Lasted for several days.
Pt received high dose flu vaccination on 9/7/21 and requested flu vaccine again.  Didn't know until vaccine batch processing at the end of the day.  Pt received another flu vaccine on 11/5/21.  Tried to contact the patient but was not able to talk to patient yet.  Left a message.
The infection control nurse at hospital received reports of two employees--one male and one female--with localized red, hot reaction at the site of an influenza vaccine injection. The male reported additional pain under the arm. A third employee reported a rash 12 hours after receiving the vaccine plus shortness of breath. Our nurse contacted the manufacturer about her concern that the 5/8 inch needle on the pre-filled syringe was too short in most cases for proper administration of this IM preparation. If the vaccine was being delivered into the SC tissue instead of muscle, would adverse reactions be increased and would clinical efficacy be diminished. Response from manufacturer quoted that decision on needle size must be individualized and that 1 to 1.5 inch need length is recommended for IM injection into the deltoid muscle in all adults. Based on this information, we are puzzled why manufacturer chose to package their products with a 5/8 inch needle.
Bumps formed under armpits and groin.  These bumps lasted about a week, except for one small bump that is still present in the groin area.  Also enamel on teeth thinned out, with teeth cracking as a result.
Back pain; Joint pain; Sore throat; Malaise; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A unspecified age non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on the left arm on 11Mar2021 at 10:45 as a single dose for COVID-19 Immunisation. The patient's medical history was not reported. The patient was allergic to bactrum. The patients concomitant medication included bupropion (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), multi vitamin (MANUFACTURER UNKNOWN), vitamin D3 (MANUFACTURER UNKNOWN) for unknown indication from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. The patient experienced back pain, fatigue, headache, joint pain, malaise and sore throat on 12Mar2021 at 17:00. No therapeutic measures were taken for the event of back pain, fatigue, headache, joint pain, malaise and sore throat. At the time of report, the clinical outcome of the events back pain, fatigue, headache, joint pain, malaise and sore throat were not recovered.   Information about lot/batch number cannot be obtained. No further information is expected.
Redness and edema @ site of varicella vaccine, 2 1/4 inches in diameter (48mm); no burning, itching, or sensitivity to touch.
Blood pressure to be very high (188/100); Elevated temperature; Sleeping a lot; Fatigue; Body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (Blood pressure to be very high (188/100)) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included AMLODIPINE and LISINOPRIL for Hypertension.   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced BODY TEMPERATURE INCREASED (Elevated temperature), SOMNOLENCE (Sleeping a lot), FATIGUE (Fatigue) and MYALGIA (Body aches). On 23-Apr-2021, the patient experienced HYPERTENSION (Blood pressure to be very high (188/100)) (seriousness criterion medically significant). On 24-Apr-2021, HYPERTENSION (Blood pressure to be very high (188/100)), BODY TEMPERATURE INCREASED (Elevated temperature), SOMNOLENCE (Sleeping a lot), FATIGUE (Fatigue) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Blood pressure measurement: 188/100 (High) went for a routine health check up and found his blood pressure to be very high (188/100).  Patient reported normally his Blood Pressure is between 120-130.Treatment for the event included ibuprofen. The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable. This case concerns a 60-year-old male with a serious unexpected event of hypertension, and nonserious unexpected body temperature increased, somnolence and expected fatigue, myalgia. Event onset 2 days after first dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a 60-year-old male with a serious unexpected event of hypertension, and nonserious unexpected body temperature increased, somnolence and expected fatigue, myalgia. Event onset 2 days after first dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient reports that yesterday night on 02/14/2020 her right arm felt sore and she felt a lump there, the symptoms once began did not get better or worse. She reported the symptoms to her supervisor when she arrived at work on 02/15/2020. Patient works at a company that has their nurses give their own employees the Hep B vaccine, and her vaccine was administered here at our center on 02/06/2020. A Nurse inspected right arm and there was no drainage, no redness, no warmth, but there was  palpated area of induration approx. 0.5cm x 0.5cm and mild pain at site. Cold pack provided with no relief. Health management notified, Patient states she has an established appointment with her PCP on 01/17/2020 and will follow up there.
Patient fainted within a few minutes of vaccine administration. Patient rested and had a couple pieces of candy and water.
1. Fevers 2. Chills 3. Body aches 4. Soreness at site of injection 5. Deliriousness 6. Extreme weakness  Symptoms Lasted for about 48 hours post vaccination time.  Was pregnant at the of the second shot (4 weeks pregnant - 01/12/2021). Expected due date was 09/15/2021. Had a sound heartbeat at 8 weeks (02/11/2021). Lost the heartbeat at 12 weeks(03/03/2021). Had a natural miscarriage at 13 weeks (03/09/20201).
Dizziness, loss of consciousness/faint, vision changes, ringing in ears, sweating, lowered heart rate, nausea.
About 10 minutes after injection, pt started having itching in the left (injection side) arm. Pt then started having itching on the other arm, then progressed to whole body itching. This became tingling. Some rash noted. Pt BP 132/88, HR 79, SpO2 99% RA. Denies difficulty breathing.  About 30 min post vaccine she said her "throat felt tight".  Pt started shaking and feeling woozy. 45 min post vaccine, Benadryl 50 mg IM given.  Pt complained of feeling hot and cold.  VS 45 min post vaccine BP116/78, HR 84, SpO2 98% RA.  VS 1 hr post vaccine BP 112/84, HR 73, SpO2 99% RA Tingling becoming worse. 1 hr 10 min post vaccine pt complains of "throat feeling puffy".  Pt complains of nausea. 1 hr 20 min post vaccine  BP 128/100 HR 68 SpO2 98% RA. 1 hr 35 min post vaccine pt states "tongue feeling heavy" decreased sensation to extremities. 1 hr 50 min post vaccine VS 134/84, HR 72, SpO299 RA,  RR16. Pt up to bathroom, unsteady on feet. Able to drink water.  2 hr 20 min post vaccine VS 130/100 HR 74, SpO2 99RA.
patient reported feeling of hot flashes and head pounding; patient informed pharmacist about the reaction 2 hours after the vaccination.  Pt felt better after taking Tylenol.
Customer returned the next day with localized swelling redness limited ability to left arm and mild fever.
I started running a fever; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EH9899)  intramuscular in the arm on 22Dec2020 at single dose for COVID-19 immunization.  Medical history included depression, allergy, high cholesterol, asthma, thyroid disorder. Concomitant medication included sertraline, bupropion and atorvastatin for High cholesterol. The patient started running a fever (non-serious) on Dec2020.  Patient worked at the day care center that provided care for the Doctor's and Nurses Children. She worked at a healthcare site, she was not a doctor or a pharmacist, so that's how she got a vaccine.Patient stated she got vaccine on 22Dec2020  and on 26Dec2020 she took her son, he was 24, to the doctor and he tested for Covid, now up to that point she had no side effects or anything, he did not get a vaccine so she wasn't surprised when he came down with it on his own but well she was surprised, last night she started running a fever so she was wondering "will the vaccine effect a Covid Test?" (as reported). Patient was treated with paracetamol (TYLENOL) and final outcome of the event was unknown.
confirmed positive test; confirmed positive test; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Batch/Lot number: unknown), on 14Apr2021 as dose 2, single (Batch/Lot number: unknown) and on 06Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 02Jan2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hodgkins disease" (unspecified if ongoing); "two stem cell transplants" (unspecified if ongoing), notes: two stem cell transplants; "Post Transplant Lymphoperphial Disease" (unspecified if ongoing), notes: Post Transplant Lymphoperphial Disease. Concomitant medication(s) included: LEVOTHYROXINE; METOPROLOL; PRAVASTATIN; NITROFURANTOIN. Past drug history included: Erythromycin, reaction(s): "allergy: erythromycin", notes: known allergies erythromycin. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "confirmed positive test". Clinical course: On day 12 after testing negative on day 11, her nose was itchy and runny. Day 13 patient took another home covid test and was positive. Patient took an additional covid test (different brand) and confirmed positive test. Began isolating again. Patient received Paxlovid from 14Jun2022 to  19Jun2022 for COVID-19 treatment. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Positive, notes: I took an additional covid test (different brand); (Jun2022) Negative, notes: testing negative on day 11; (Jun2022) Positive, notes: home covid test and was positive- Day 13. Therapeutic measures were taken as a result of vaccination failure, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fatigue and headache for 4-30 hours after vaccine Red rash without itching at injection site about 9 days after injection Tenderness at site for a week
pt recv vax 5NOV96 & was exposed to varicella x 3wk from siblings 30-50 papules & vesicles over body;
No adverse symptoms noted. Vaccines were administered five days earlier than minimum valid date.  Provider in office was notified. Father was also notified while in office and advised vaccines will need to be given again. Father educated to monitor for signs of adverse reactions and advised to report them. Father verbalized understanding.
Daughter called on 07/19/21 and stated patient had a CVA on 01/17/2021.  Patient was transported to Hospital and patient died on 01/23/2021.
Few seconds after the vaccine I felt a big metallic taste in my mouth. During observation I started feeling super super hot, sweaty and shaky, like I was closing in, a feeling like I was going to pass out. I also had a headache. My coworkers noticed I was bright red on my face. Cool rags and icy waters. The shaky, the sweats went away after about 30 min but I was left with a headache for about a week.  Later that evening the body aches and the chills (not really a fever, it bounced between 99. 9 and 100.4F) were off and on I do not remember for how many days.
My husband is having hard time swallowing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (My husband is having hard time swallowing) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPHAGIA (My husband is having hard time swallowing). At the time of the report, DYSPHAGIA (My husband is having hard time swallowing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 23-JUN-2016, the patient was inadvertently vaccinated with an expired dose of ZOSTAVAX 19400 PFU, lot # K018176, expiry date: 10-JAN-2016 (dose, vaccination site and route unspecified). No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Pt was admitted to OB to have a baby, incidentally Covid +, no sympotoms Covid vaccine Dose 1 given 5/19/2021 Pfizer Lot # EW0187
Around noon, my fiance doubled over in agonising pain and clutched his right side. We treated it like a stomach ache and he went through the rest of the day, even at work, in gut wrenching pain. This morning when I woke up, I noticed he was out on the couch. When I went to check on him, he was as white as a ghost and his lips were greying around the edges. I immediately told him to call into work. I thought he would say no because he has not called in in over 10 years, but to my surprise, he did so. I put him in bed and the abdominal pain is still present and now his fever is over 103!!!  I bought Tylenol and Motrin and will be alternating between the two until the fever breaks and if the pain persists by 8 pm, we will be headed to the emergency room...
Patient reported today that he felt ill starting 24 hours after receiving his 3rd dose of Pfizer. He said he was fatigued, body aches, upset stomach and generally felt unable to do anything but rest. These symptoms persisted for 13 days and he is now starting to recover.
CDC reports: 2 mo infant developed rash described as white & red spots w/swelling of hands & feet following DTP/OPV immun, lasted 2 days.
Patient had several red indurated rings across her deltoid and bicep with swelling and pain down to her elbow (in (R) deltoid area).
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality. The reporter is the patient.  A 46-year-old male patient received BNT162b2 (BNT162B2), on 31Aug2021 as dose 3 (booster), single (Lot number: FL8094) at the age of 45 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 02Aug2022, outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29Jul2022) Negative; (02Aug2022) Positive. Therapeutic measures were taken as a result of covid-19. Patient recieved paxlovid as treatment. Clinical course: Paxlovid Rebound. No symptoms and tested negative on 29Jul2022. Runny nose on 02Aug2022 and tested positive again that evening. patient was not taking any other medications within 2 weeks of starting COVID-19 treatment patient received previously receive a COVID-19 Vaccine. patient is Recovering with not ae treatment. Patient had no known allergies.